We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Sugar Supplement Fuels the Failing Heart

By Biotechdaily staff writers
Posted on 03 Apr 2007
D-ribose, a simple, five-carbon sugar, has been shown to improve functional capacity, quality of life, and everyday activities for patients afflicted with congestive heart failure (CHF).
D-Ribose, unlike glucose, is a 5-carbon monosaccharide (pentose sugar) important for DNA, RNA, and most importantly, adenosine tri-phosphate (ATP), the energy currency of the cells. More...
ATP is crucial in maintaining the integrity and function of every cell, which is necessary for day-to-day health. By helping to replenish ATP supply, ribose increases cardiac energy reserves that become depressed during ischemia or hypoxia associated with coronary artery disease (CAD) or CHF by improving diastolic function.
Bioenergy Ribose is a dietary additive for energy enhancement. About 2-5 gm are generally adequate for added energy. To maximize athletic performance, assist CHF patients, or to keep energy pools high during strenuous activity, slightly larger doses may be required. Bioenergy Ribose, a product of Bioenergy Life Science (Minneapolis, MN, USA), is a mildly sweet, completely soluble food supplement. It mixes easily with juice, milk, or other cold foods.
"The number of heart failure patients continues to grow every year. By replenishing ATP to an energy-deficient heart we can significantly improve a patient's quality of life,” said John St. Cyr, M.D., Ph.D., medical director of Bioenergy Life Science. "We've learned recently that patients with heart disease may have a deficient supply of high energy compounds. Past studies have demonstrated that D-ribose supplementation enhances the return of ATP levels with an associated improvement in diastolic function.”

In the body, ribose is made from glucose (a simple six-carbon sugar) through a pathway called the pentose phosphate pathway (PPP) or hexose monophosphate shunt (HMS). The physiologically functional form of ribose, called 5-phosphoribosyl-1-pyrophosphate (PRPP), regulates the metabolic pathway that synthesizes energy compounds in all living tissue.



Related Links:
Bioenergy Life Science

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.